ZLAB vs. JD
ZLAB (Zai Lab Limited) and JD (JD.com, Inc.) are both stocks. ZLAB operates in Biotechnology (Healthcare), while JD operates in Internet Retail (Consumer Cyclical). Over the past 5 years, ZLAB returned -36.89%/yr vs -14.95%/yr for JD. At a 0.38 correlation, their price movements are largely independent.
Performance
ZLAB vs. JD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZLAB achieves a -2.66% return, which is significantly lower than JD's 6.13% return.
ZLAB
- 1D
- 0.12%
- 1M
- -19.09%
- YTD
- -2.66%
- 6M
- -13.06%
- 1Y
- -44.84%
- 3Y*
- -21.65%
- 5Y*
- -36.89%
- 10Y*
- —
JD
- 1D
- -2.45%
- 1M
- -2.10%
- YTD
- 6.13%
- 6M
- 1.97%
- 1Y
- -6.02%
- 3Y*
- -3.08%
- 5Y*
- -14.95%
- 10Y*
- 3.86%
ZLAB vs. JD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZLAB Zai Lab Limited | -2.66% | -32.65% | -4.17% | -10.98% | -51.15% | -53.56% | 225.41% | 79.11% | 9.37% | -23.99% |
JD JD.com, Inc. | 6.13% | -14.78% | 23.45% | -47.76% | -17.87% | -20.28% | 149.50% | 68.32% | -49.47% | -6.80% |
Correlation
The correlation between ZLAB and JD is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Sep 21, 2017 | 0.38 |
The correlation between ZLAB and JD shifts across timeframes, from 0.22 (1 year) to 0.42 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ZLAB:
$1.90B
JD:
$42.13B
ZLAB:
-$1.62
JD:
$9.38
ZLAB:
4.17
JD:
0.03
ZLAB:
2.87
JD:
0.20
ZLAB:
$453.28M
JD:
$1.32T
ZLAB:
$262.53M
JD:
$126.44B
ZLAB:
-$183.84M
JD:
$27.03B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZLAB vs. JD — Risk / Return Rank
ZLAB
JD
ZLAB vs. JD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zai Lab Limited (ZLAB) and JD.com, Inc. (JD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZLAB | JD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.81 | -0.19 | -0.62 |
Sortino ratioReturn per unit of downside risk | -1.12 | -0.05 | -1.07 |
Omega ratioGain probability vs. loss probability | 0.88 | 0.99 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | -0.72 | -0.20 | -0.52 |
Martin ratioReturn relative to average drawdown | -1.02 | -0.41 | -0.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ZLAB | JD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.81 | -0.19 | -0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.49 | -0.28 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.08 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | 0.08 | -0.16 |
Drawdowns
ZLAB vs. JD - Drawdown Comparison
The maximum ZLAB drawdown since its inception was -92.84%, which is greater than JD's maximum drawdown of -79.12%. Use the drawdown chart below to compare losses from any high point for ZLAB and JD.
Loading charts...
Drawdown Indicators
| ZLAB | JD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.84% | -79.12% | -13.72% |
Max Drawdown (1Y)Largest decline over 1 year | -62.12% | -29.78% | -32.34% |
Max Drawdown (3Y)Largest decline over 3 years | -62.12% | -48.10% | -14.02% |
Max Drawdown (5Y)Largest decline over 5 years | -92.31% | -75.63% | -16.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -79.12% | — |
Current DrawdownCurrent decline from peak | -91.04% | -68.59% | -22.45% |
Average DrawdownAverage peak-to-trough decline | -53.30% | -37.56% | -15.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.17% | 14.79% | +29.38% |
Volatility
ZLAB vs. JD - Volatility Comparison
Zai Lab Limited (ZLAB) has a higher volatility of 15.84% compared to JD.com, Inc. (JD) at 12.38%. This indicates that ZLAB's price experiences larger fluctuations and is considered to be riskier than JD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZLAB | JD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.84% | 12.38% | +3.46% |
Volatility (6M)Calculated over the trailing 6-month period | 35.38% | 22.57% | +12.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.86% | 32.39% | +23.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.07% | 53.77% | +22.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.44% | 47.83% | +20.61% |
Dividends
ZLAB vs. JD - Dividend Comparison
ZLAB has not paid dividends to shareholders, while JD's dividend yield for the trailing twelve months is around 3.40%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
JD JD.com, Inc. | 3.40% | 3.48% | 2.19% | 2.15% | 2.24% |
ZLAB Zai Lab Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ZLAB vs. JD - Financials Comparison
This section allows you to compare key financial metrics between Zai Lab Limited and JD.com, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZLAB vs. JD - Profitability Comparison
ZLAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zai Lab Limited reported a gross profit of 61.30M and revenue of 99.61M. Therefore, the gross margin over that period was 61.5%.
JD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, JD.com, Inc. reported a gross profit of 52.43B and revenue of 313.78B. Therefore, the gross margin over that period was 16.7%.
ZLAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zai Lab Limited reported an operating income of -69.39M and revenue of 99.61M, resulting in an operating margin of -69.7%.
JD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, JD.com, Inc. reported an operating income of 3.78B and revenue of 313.78B, resulting in an operating margin of 1.2%.
ZLAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zai Lab Limited reported a net income of -51.02M and revenue of 99.61M, resulting in a net margin of -51.2%.
JD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, JD.com, Inc. reported a net income of 5.07B and revenue of 313.78B, resulting in a net margin of 1.6%.
Frequently Asked Questions
ZLAB and JD have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZLAB has higher volatility (15.84%) compared to JD (12.38%). In terms of maximum drawdown, ZLAB dropped -92.84% vs JD's -79.12%.
JD currently has the higher Sharpe Ratio (-0.19 vs -0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZLAB and JD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer